Oncology Nursing News®

Register for a live broadcast to learn more about TRODELVY (sacituzumab govitecan-hziy) with Dr. Hope S. Rugo

Oncology Nursing Articles

FDA Grants Naxitamab Priority Review for High-Risk Neuroblastoma

FDA Grants Naxitamab Priority Review for High-Risk Neuroblastoma

BY KRISTI ROSA

Better Palliative Care Integration Needed for Clinical Trial Participants

Better Palliative Care Integration Needed for Clinical Trial Participants

BY BRIELLE BENYON

Novel Drug Appears Safe and Active for Advanced Solid Tumors

Novel Drug Appears Safe and Active for Advanced Solid Tumors

BY CAROLINE SEYMOUR

Infigratinib Is Active in Metastatic Urothelial Cancer

Infigratinib Is Active in Metastatic Urothelial Cancer

BY GINA COLUMBUS

Nurse-Led Telephone Triage Decreases Hospitalizations and Cancer Costs

Nurse-Led Telephone Triage Decreases Hospitalizations and Cancer Costs

BY BRIELLE BENYON

Oncology Nursing News Top Stories: May 2020

Oncology Nursing News Top Stories: May 2020

BY JESSICA SKARZYNSKI

Relugolix May Become New Standard of Care for Advanced Prostate Cancer

Relugolix May Become New Standard of Care for Advanced Prostate Cancer

BY HANNAH SLATER

International Pediatric Cancer Registry Can Improve Outcomes

International Pediatric Cancer Registry Can Improve Outcomes

BY TONY BERBERABE, MPH

FDA Approves Ramucirumab + Erlotinib for Firstline EGFR+ NSCLC

FDA Approves Ramucirumab + Erlotinib for Firstline EGFR+ NSCLC

BY JASON M. BRODERICK

3-Drug Carfilzomib Regimen Not Superior Than Standard of Care in Myeloma

3-Drug Carfilzomib Regimen Not Superior Than Standard of Care in Myeloma

BY JESSICA SKARZYNSKI

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.